GV
Goluguri Venkata Krishna Reddy
About Goluguri Venkata Krishna Reddy
Data last updated:
Goluguri Venkata Krishna Reddy is a Partner at Nithyamruthas Grands Llp (since 2025) and Director at Risevin Pharmaceuticals Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 24 Nov 2025 | 2025 | Active | ||
| Director | 30 Nov 2024 | 2024 | Active |
Board colleagues of Goluguri Venkata Krishna Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Moulika Satthi | 10195483 | Nithyamruthas Grands Llp | Designated Partner |
| Venkata Reddy Poluri | 10857219 | Nithyamruthas Grands Llp , Risevin Pharmaceuticals Private Limited | Designated Partner |
| Yamani Sakuntala Valisetty | 11392705 | Nithyamruthas Grands Llp | Designated Partner |
| Srinivas Reddy Vudumula | 10857217 | Risevin Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Goluguri Venkata Krishna Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Goluguri Venkata Krishna Reddy
Goluguri Venkata Krishna Reddy currently holds 2 directorships: Nithyamruthas Grands Llp (Partner, since 24 Nov 2025); Risevin Pharmaceuticals Private Limited (Director, since 30 Nov 2024).
Goluguri Venkata Krishna Reddy was first appointed on 30 Nov 2024 as Director at Risevin Pharmaceuticals Private Limited. The most recent appointment on record is 24 Nov 2025 at Nithyamruthas Grands Llp.
The current boards of Goluguri Venkata Krishna Reddy's companies include Moulika Satthi (Nithyamruthas Grands Llp), Venkata Reddy Poluri (Nithyamruthas Grands Llp), Yamani Sakuntala Valisetty (Nithyamruthas Grands Llp), Srinivas Reddy Vudumula (Risevin Pharmaceuticals Private Limited).